Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.

OBJECTIVES This study sought to investigate factors associated with restenosis after endovascular therapy comparing TASC (Trans-Atlantic Inter-Society Consensus) II classes A to C with class D femoropopliteal (FP) lesions. BACKGROUND It is unclear whether the determinants of restenosis for TASC II class D lesions are the same as those for TASC II classes A to C FP lesions. METHODS We studied 2,400 limbs from 1,889 consecutive patients (73 ± 17 years of age; 31% women; 30% critical limb ischemia) who underwent successful endovascular therapy for de novo FP lesions. Predictors for restenosis in TASC II classes A to C and class D lesions were assessed using a Cox proportional hazards model. RESULTS The 5-year primary patency rate was 50% in TASC II classes A to C and 34% in TASC II class D lesions, respectively (p < 0.001). Overall, restenosis had a significant interaction with sex and renal failure (both p < 0.01). Female sex was a significant risk factor for restenosis in TASC II class D lesions (adjusted hazard ratio [HR]: 1.80, p < 0.001) but not TASC II classes A to C lesions (adjusted HR: 1.10, p = 0.352). Conversely, renal insufficiency was a significant risk factor for restenosis in TASC II classes A to C lesions (adjusted HR: 1.43, p < 0.001) but not TASC II class D lesions (adjusted HR: 0.79, p = 0.129). Diabetes mellitus, no stent use, chronic total occlusion, and poor below-the-knee runoff were shared risk factors for restenosis between TASC II classes A to C and class D lesions (all p < 0.05). CONCLUSIONS For de novo FP lesions, diabetes, no stent use, chronic total occlusion, and poor below-the-knee runoff were shared restenosis predictors for TASC II classes A to C and class D lesions, whereas renal failure was a predictor for TASC II classes A to C lesions and female sex for TASC II class D lesions.

[1]  K. Urasawa,et al.  Cilostazol Reduces Angiographic Restenosis After Endovascular Therapy for Femoropopliteal Lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol Study , 2013, Circulation.

[2]  I. Baumgartner,et al.  Below-the-Knee Angioplasty in Patients with End-Stage Renal Disease , 2005, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[3]  P. Teirstein,et al.  Final Results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) Study , 2000 .

[4]  E. Boerwinkle,et al.  Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study , 2003, Vascular medicine.

[5]  L. Chambless,et al.  Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study. , 2005, American journal of preventive medicine.

[6]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004 .

[7]  T. Lehnert,et al.  Angioplasty of the pelvic and femoral arteries in PAOD: results and review of the literature. , 2010, European journal of radiology.

[8]  J. Davaine,et al.  One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artère fémorale superficielle" cohort). , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[9]  Raimund Erbel,et al.  [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.

[10]  Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery , 2006 .

[11]  A. Bolia,et al.  Subintimal angioplasty for femoro-popliteal occlusive disease. , 2010, Journal of vascular surgery.

[12]  B. Seifert,et al.  The influence of gender on the outcome of arterial procedures in the lower extremity. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  Thomas Zeller,et al.  Current state of endovascular treatment of femoro-popliteal artery disease , 2007, Vascular medicine.

[14]  F. Setacci,et al.  Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  Maurice Buchbinder,et al.  Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: Twelve-Month Results From the RESILIENT Randomized Trial , 2010, Circulation. Cardiovascular interventions.

[16]  S. Lipsitz,et al.  Disparity in Outcomes of Surgical Revascularization for Limb Salvage: Race and Gender Are Synergistic Determinants of Vein Graft Failure and Limb Loss , 2009, Circulation.

[17]  G. Morris-Stiff,et al.  Variations in the anatomical distribution of peripheral vascular disease according to gender. , 2011, Annals of the Royal College of Surgeons of England.

[18]  D. Scheinert,et al.  Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST) , 2007, Circulation.

[19]  A. Creutzig,et al.  Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. , 1992, Ultrasound in medicine & biology.

[20]  N. Weissman,et al.  The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. , 2008, European heart journal.

[21]  Nancy M Albert,et al.  Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.